ロード中...
Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets
The treatment of type II DM involves the use of combination of drugs, especially at the chronic stage. However, the pill burden of this combination therapy combined with swallowing difficulties, occurring at a later stage of DM, has been the major challenge for successful treatment outcomes. This st...
保存先:
| 出版年: | Adv Pharmacol Pharm Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7094173/ https://ncbi.nlm.nih.gov/pubmed/32259103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3546597 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|